| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 12/17/2009 | WO2009151584A2 Identification of contaminating bacteria in industrial ethanol fermentations |
| 12/17/2009 | WO2009151518A2 Methods and compositions for predicting development of atopic diseases |
| 12/17/2009 | WO2009151448A1 Thymidylate synthase haplotype is associated with tumor recurrence in stage ii and stage iii colon cancer patients |
| 12/17/2009 | WO2009151314A1 Classification and risk-assignment of childhood acute lymphoblastic leukaemia (all) by gene expression signatures |
| 12/17/2009 | WO2009151313A1 A novel antiviral peptide against avian influenza virus h9n2 |
| 12/17/2009 | WO2009151150A1 Method for detecting or quantifying dna |
| 12/17/2009 | WO2009151149A1 Method for detecting or quantifying dna |
| 12/17/2009 | WO2009150845A1 Method for selection of most suitable anti-viral agent |
| 12/17/2009 | WO2009150839A1 Diagnosis/treatment option for head-and-neck tumor using micro-rna as biomarker |
| 12/17/2009 | WO2009150789A1 Method for testing for the risk of coronary artery spasm |
| 12/17/2009 | WO2009150631A2 Single-molecule pcr for amplification from single strand polynucleotides |
| 12/17/2009 | WO2009150550A2 Genetic component of complications in type 2 diabetes |
| 12/17/2009 | WO2009150494A1 Human mena isoforms serve as markers of epithelial to mesenchymal transition and sensitivity to egfr inhibition in human cancer cells |
| 12/17/2009 | WO2009150491A2 Interferon epsilon (ifne1) as a marker for targeted cancer therapy |
| 12/17/2009 | WO2009150467A1 Isothermal nucleic acid amplification |
| 12/17/2009 | WO2009150256A1 Markers for predicting response and survival in anti-egfr treated patients |
| 12/17/2009 | WO2009150255A2 Markers for predicting response and survival in anti-egfr treated patients |
| 12/17/2009 | WO2009150244A1 Swi5 gene as a diagnostic target for the identification of fungal and yeast species |
| 12/17/2009 | WO2009150243A1 Ace2 as a target gene for the molecular identification of yeast and fungal species |
| 12/17/2009 | WO2009150242A2 P2/p2a/p2b gene sequences as diagnostic targets for the identification of fungal and yeast species |
| 12/17/2009 | WO2009150241A2 EIF2γ GENE AS A DIAGNOSTIC TARGET FOR THE IDENTIFICATION OF FUNGAL AND YEAST SPECIES |
| 12/17/2009 | WO2009150229A1 Tet2 as a new diagnostic and pronostic marker in hematopoietic neoplasms |
| 12/17/2009 | WO2009150221A1 A method for autism prediction |
| 12/17/2009 | WO2009150218A1 A combination of risk alleles associated with autism |
| 12/17/2009 | WO2009150216A1 A method for predicting the response to a treatment with anakinra |
| 12/17/2009 | WO2009150127A1 A method for predicting responsiveness to a treatment with an anti-her2 antibody |
| 12/17/2009 | WO2009149915A1 Anti-bacterial ligase inhibitors |
| 12/17/2009 | WO2009149578A1 Use of gene in the synthesis of astaxanthin |
| 12/17/2009 | WO2009131887A3 Methods of using mir210 as a biomarker for hypoxia and as a therapeutic agent for treating cancer |
| 12/17/2009 | WO2009129524A3 High-throughput plasmid dna preparation |
| 12/17/2009 | WO2009125295A3 Genetic markers of mmp- 12 gene for wound development |
| 12/17/2009 | WO2009122441A3 Method of cloning stable stress tolerant superoxide dismutase using degenerate primers |
| 12/17/2009 | WO2009120374A3 Methods and compositions for nucleic acid sample preparation |
| 12/17/2009 | WO2009117539A3 Bioluminescent construct |
| 12/17/2009 | WO2009117415A3 Genetic indicators of weight loss |
| 12/17/2009 | WO2009117031A3 System and method for nucleotide sequence profiling for sample identification |
| 12/17/2009 | WO2009115660A3 En masse selection of cells expressing extracellular enzymes in a compartmented selective environment |
| 12/17/2009 | WO2009113888A3 Method for determining reduced predisposition to cancer based on genetic profile |
| 12/17/2009 | WO2009067546A3 Lung cancer markers and uses thereof |
| 12/17/2009 | WO2009031054A3 Methods and compositions for isolating nucleic acid sequence variants |
| 12/17/2009 | WO2008109423A8 Multigene assay to predict outcome in an individual with glioblastoma |
| 12/17/2009 | WO2008100344A8 Fluorescent methods and materials for directed biomarker signal amplification |
| 12/17/2009 | WO2007131238A8 Compounds and methods for modulating expression apob |
| 12/17/2009 | US20090313725 Gibberellin 2-Oxidase Genes And Uses Thereof |
| 12/17/2009 | US20090313720 Delta-8 desaturase and its use in making polyunsaturated fatty acids |
| 12/17/2009 | US20090313709 Genetically Modified Animal and Use Thereof |
| 12/17/2009 | US20090313708 Gpr22 and methods relating thereto |
| 12/17/2009 | US20090313707 Novel Gene Disruptions, Compositions and Methods Relating Thereto |
| 12/17/2009 | US20090312951 Method for Calculation of Statistical Characteristics for a Set of Gene Expression Values |
| 12/17/2009 | US20090312596 Assay and kit for predicting implantation success in assisted fertilisation |
| 12/17/2009 | US20090312533 Single copy genomic hybridization probes and method of generating same |
| 12/17/2009 | US20090312527 Novel monoclonal antibodies against HPV proteins |
| 12/17/2009 | US20090312415 Remedy/preventive for vascular disorders and hypertension and method of screening the same |
| 12/17/2009 | US20090312411 Preventing or reducing risk of miscarriages |
| 12/17/2009 | US20090312410 Genetic polymorphisms associated with coronary heart disease, methods of detection and uses thereof |
| 12/17/2009 | US20090312405 Methods to Predict and Prevent Resistance to Taxoid Compounds |
| 12/17/2009 | US20090312396 Methods for cancer treatment using tak1 inhibitors |
| 12/17/2009 | US20090312395 Assay |
| 12/17/2009 | US20090312391 Unifying mechanism and methods to prevent cancer and neurodegenerative diseases |
| 12/17/2009 | US20090312376 5-(4-methanesulfonyl-phenyl)-thiazole derivatives for the treatment of acute and chronic inflammatory diseases |
| 12/17/2009 | US20090312363 Bifunctional histone deacetylase inhibitors |
| 12/17/2009 | US20090312298 Methods and Compositions Related to GABA Receptor Subunits |
| 12/17/2009 | US20090312285 Biological specimen collection and transport system and methods of use |
| 12/17/2009 | US20090312284 Histone deacetylase inhibitors with combined activity on class-i and class-iib histone deacetylases in combination with proteasome inhibitors |
| 12/17/2009 | US20090312263 Gene Differentially Expressed in Breast and Bladder Cancer and Encoded Polypeptides |
| 12/17/2009 | US20090312253 Methods of effecting Wnt signaling through Dkk structural analysis |
| 12/17/2009 | US20090312251 Methods of regulating differentiation in mammals |
| 12/17/2009 | US20090312245 SRA binding protein |
| 12/17/2009 | US20090312198 Controlled evaporation, temperature control and packaging for optical inspection of biological samples |
| 12/17/2009 | US20090312191 Method and system for the detection of atypical sequences via generalized compositional methods |
| 12/17/2009 | US20090311792 Fibroblast growth factor (FGF23) and methods for use |
| 12/17/2009 | US20090311769 Thermostable luciferases and methods of production |
| 12/17/2009 | US20090311746 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (mva) |
| 12/17/2009 | US20090311741 Environmental evaluation installation and environmental evaluation method |
| 12/17/2009 | US20090311740 Colorimetric method and relative device for bacterial load detection |
| 12/17/2009 | US20090311739 Device for activating a self-contained biological indicator |
| 12/17/2009 | US20090311738 Method and system for determining properties of biological cells |
| 12/17/2009 | US20090311737 Method and device for generating diffusive gradients in a microfluidic chamber |
| 12/17/2009 | US20090311736 Integrated apparatus and method to detect inflammatory states present in a sample of whole blood |
| 12/17/2009 | US20090311735 Method for stem cell culture and cells derived therefrom |
| 12/17/2009 | US20090311734 Laser Illumination System in Fluorescent Microscopy |
| 12/17/2009 | US20090311733 Enrichment Unit for Biological Components and an Enrichment Method |
| 12/17/2009 | US20090311732 Analytical method for analyzing c-terminus truncation |
| 12/17/2009 | US20090311731 Modified Molecule |
| 12/17/2009 | US20090311730 Measuring thrombin activity in whole blood |
| 12/17/2009 | US20090311725 Polypeptide producing cells |
| 12/17/2009 | US20090311719 In vitro method for diagnosing neurodegenerative diseases |
| 12/17/2009 | US20090311717 Microfluidic chip design comprising capillaries |
| 12/17/2009 | US20090311714 Methods for the Screening of Antibacterial Substances |
| 12/17/2009 | US20090311713 Method of Detecting an Analyte |
| 12/17/2009 | US20090311712 Method of screening multiple single nucleotide polymorphisms associated with susceptibility to specific disease or drug response |
| 12/17/2009 | US20090311711 CRH and POMC Effects on Animal Growth |
| 12/17/2009 | US20090311710 Mutagenesis methods using ribavirin and/or rna replicases |
| 12/17/2009 | US20090311709 Compositions, Methods, and Kits for (MIS)Ligating Oligonucleotides |
| 12/17/2009 | US20090311708 Method of determining a chemotherapeutic regimen based on ercc1 and ts expression |
| 12/17/2009 | US20090311707 O-glycans as diagnostic markers for inflammatory bowel disease |
| 12/17/2009 | US20090311706 Quantitative analysis of in vivo mutation at the pig-a locus |
| 12/17/2009 | US20090311705 Method of determining efficiency of ovum collection in bovine |
| 12/17/2009 | US20090311704 Compositions and methods for diagnosis of autophagic vacuolar myopathy |
| 12/17/2009 | US20090311703 Methods for identifying factors for differentiating definitive endoderm |